A series of 3-(alkyl(dialkyl)amino)benzofuro[2,3-f]quinazolin-1(2H)-ones was reported.
The synthesis of these benzofuroquinazolinones was performed in a one-pot reaction.
DPA-HBFQ-1 inhibits ERα+, ERα− and tamoxifen-resistant breast cancer cells growth.